Gilead announced results from phase 3 trial of investigational antiviral Remdesivir in patients with severe COVID-19
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…
-
-
Hologic to introduce second high-throughput molecular assay for novel Coronavirus (SARS-CoV-2)
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaﾮ molecular assay to detect…
-
Clinical trial began to see if convalescent plasma can treat COVID-19
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
-
Windtree announced first patient enrolled in AEROSURF bridging study for treatment of Respiratory Distress Syndrome
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
-
Illumina’s donation to Africa Centre for Disease Control expanded capability for sequencing-based COVID-19 surveillance
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
-
Secarna Pharma entered into cooperation with Guangzhou’s Sun Yat-sen University to develop treatment for SARS-CoV-2 viral infections
On Apr. 28, 2020, Secarna Pharmaceuticals announced that the Company had entered into a cooperation with the First…
-
Sarepta Therapeutics announced research agreement with U.S. DoD to evaluate multiple constructs from proprietary RNA platform as treatments for COVID-19
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
-
INOVIO and GeneOne reported positive phase 1/2a clinical data with DNA vaccine INO-4700 for MERS Coronavirus
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase 1/2a…
-
Entos Pharmaceuticals partnered with EpiVax to develop a pan-Coronavirus DNA vaccine
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax, a world leading informatics and immunology biotechnology…
-
Dutch consortium began production of millions of medical face masks for healthcare professionals in the Netherlands
On Apr. 28, 2020, the Dutch consortium of AFPRO Filters, Royal Auping, and Royal DSM has begun large-scale…
-
Six COVID-19 patients treated with RedHills opaganib under compassionate use show objective clinical improvement
On Apr. 27, 2020, RedHill Biopharma provided an additional update on the compassionate use program with its investigational…
-
ARTES joined global combat against Corona with virus-like particle based platform technologies
On Apr. 27, 2020, ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered…
-
Moderna announced IND Submitted to FDA for phase 2 study of mRNA vaccine (mRNA-1273) against novel Coronavirus
On Apr. 27, 2020, Moderna announced it had submitted an Investigational New Drug application to the U.S. Food…
-
Edwards HemoSphere platform receives expanded use indication from Health Canada in treatment of COVID-19 patients
On Apr. 27, 2020, Edwards Lifesciences announced that Health Canada approved an expanded indication for use of the…
-
Regeneron and Sanofi updated phase 2/3 adaptive-designed trial of Kevzara (sarilumab) in hospitalized COVID-19 patients
On Apr. 27, 2020, Regeneron and Sanofi announced preliminary results from the Phase 2 portion of an ongoing…
-
Ichor announced its TriGrid Delivery System is being utilized for delivery in non-human primates of a COVID-19 DNA vaccine being developed by Naval Medical Research Center
On Apr. 27, 2020, Ichor announced that its clinical stage TriGrid® Delivery System (TriGrid) is being utilized for…
-
Merck and Institute for Systems Biology collaborate to define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers
On Apr. 27, 2020, Merck and the Institute for Systems Biology announced a new research collaboration to investigate…
-
CTI Biopharma announced initiation of phase 3 PRE-VENT study evaluating Pacritinib in hospitalized patients with severe COVID-19
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
-
WHO reported “no evidence” that recovered COVID-19 patients cannot be reinfected
On Apr. 25, 2020, the World Health Organization (WHO) reported there was currently ‘no evidence’ that people who…
-
CIRM Board funded first clinical study for COVID-19
On Apr. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $749,999 to…
-
Keck Foundation gifted $4 million to USC to speed public health and research on COVID-19
On Apr. 24, 2020, the W. M. Keck Foundation announced a $4 million gift that will help scientists…
-
Coronavirus drifts through the air in microscopic droplets – here’s the science of infectious aerosols
On Apr. 24, 2020, Shelly Miller, Professor of Mechanical and Environmental Engineering, University of Colorado Boulder, reported that…
-
Global study to assess effects of COVID-19 in pregnancy on mothers and babies was launched
On Apr. 24, 2020, researchers at the University of Oxford announced the start of a large, international study…
-
NIAID strategic plan detailed COVID-19 research priorities
On Apr. 23, 2020, a new strategic plan from the National Institute of Allergy and Infectious Diseases (NIAID),…
-
Oxford University COVID-19 vaccine began human trial stage
On Apr. 23, 2020, University of Oxford researchers announced they had begun testing a COVID-19 vaccine in human…
-
Emergent BioSolutions signed agreement to be U.S. manufacturing partner for Johnson & Johnson’s lead vaccine candidate for COVID-19
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
-
Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
-
Caladrius Biosciences planned to assess CLBS119 cell therapy for repair of COVID-19 induced lung damage
On Apr. 23, 2020, Caladrius Biosciences announced the FDA has authorized its investigational new drug application for the…
-
LivaNova permitted to modify cardiopulmonary products’ indications for use to include ECMO therapy to address COVID-19
On Apr. 22, 2020, LivaNova announced that several of its cardiopulmonary products are now permitted to be used…
-
BARDA, Tangen Biosciences partnership pursues SARS-CoV-2 diagnostic
On Apr. 22, 2020, the Biomedical Advanced Research and Development Authority (BARDA) and Tangen Biosciences announced teaming up…
